In heart failure, salidroside can inhibit protein phosphorylation in PI3K/AKT/GSK3β pathway and protein expression of collagen-I (Col-I) and profilin-I (profilin-I) in cardiac tissue of heart failure rats, thus reducing the level of cardiac fibrosis and heart failure. Here, PFN1 is linked to heart failure.